Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival. 2010

Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
Department of Surgery, Rinku General Medical Center, Izumisano Municipal Hospital, Izumisano, Osaka, Japan.

OBJECTIVE The objective of this study was to investigate the clinicopathological features and postoperative survival of primary colorectal signet-ring cell carcinoma. METHODS Nineteen patients with primary colorectal signet-ring cell carcinoma were identified from a database of 5884 surgical patients with colorectal cancers treated surgically at Osaka University Hospital and affiliated hospitals between 1993 and 2007. The clinicopathological data of those patients were compared with those of 5792 patients with non-signet-ring cell colorectal carcinoma (5417 with well or moderately differentiated adenocarcinoma and 375 with poorly differentiated adenocarcinoma or mucinous carcinoma). RESULTS All patients showed a tumor depth of over T3. Lymph node involvement occurred in 14 patients. Seven of 19 patients presented with distant metastasis at the time of diagnosis. The overall 5-year survival rate in primary signet-ring cell carcinoma was significantly lower at 24.1%, in comparison to 77.5% in well or moderately differentiated adenocarcinoma and 57.7% in poorly differentiated adenocarcinoma or mucinous carcinoma. Likewise, the postoperative survival in Stage III was also significantly worse. On the other hand, no significant difference was observed in Stage II or IV. CONCLUSIONS The most important feature of primary colorectal signet-ring cell carcinoma is the advanced stage at the time of diagnosis. In addition, the postoperative survival is worse than for other types of colorectal cancer.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
July 2017, Anticancer research,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
January 2001, Journal of computer assisted tomography,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
December 2001, ANZ journal of surgery,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
October 2015, Intestinal research,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
June 2020, Scientific reports,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
December 2001, ANZ journal of surgery,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
January 2021, Pathology oncology research : POR,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
March 2018, Clinical colorectal cancer,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
May 2021, Molecular and clinical oncology,
Tsunekazu Mizushima, and Masaya Nomura, and Makoto Fujii, and Hiroki Akamatsu, and Hitoshi Mizuno, and Harumi Tominaga, and Junichi Hasegawa, and Kiyokazu Nakajima, and Keigo Yasumasa, and Masato Yoshikawa, and Toshirou Nishida
January 2022, Journal of healthcare engineering,
Copied contents to your clipboard!